by Five Rivers Rx | Apr 2, 2020 | Industry News
In our last Special Edition, we covered how manufacturing capacity around the globe is likely being affected, the implementation of force majeure contract clauses, and how increased pressure on the supply chain will play out (read here). This week, we provide more...
by Five Rivers Rx | Mar 12, 2020 | Industry News
As the coronavirus wreaks havoc around the globe, the pharmaceutical supply chain needs to prepare for an exceptionally tumultuous ride. Around the World As the virus spreads across the world, countries are taking drastic preventative measures to prevent the spread of...
by Five Rivers Rx | Feb 27, 2020 | Industry News
How Telemedicine Has Made Generic Drugs Sexy Since 2017, Direct-to-Consumer (DTC) startups (some engaged by Five Rivers RX!) have cropped up to market and supply drugs to patients across the United States. The product portfolio is not too exciting – including generic...
by Five Rivers Rx | Feb 12, 2020 | Five Rivers, Industry News
Over two years in the making, the light at the end of the tunnel might finally be in sight – the Drug Enforcement Administration’s (DEA) has issued a Notice for Proposed Rule making as an update to the infamous definition of a “suspicious order.” In Fall...
by Five Rivers Rx | May 9, 2019 | Industry News
The State of New York recently passed into law Assembly Bill A9507C, a seemingly mundane bill concerning “major components of legislation necessary to implement the state health and mental hygiene budget for the 2018-2019 state fiscal year.”¹ However, this bill may...
by Five Rivers Rx | May 9, 2019 | Industry News
We have received a lot of questions over the past few weeks on how the lawsuit is progressing and what it will mean for the industry. Although we do not have any definitive answers yet (a court decision could come as early as June), we do have some highlights from our...
